recombinant mouse tgf-beta 1 protein Search Results


96
R&D Systems tgf β1
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
Tgf β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgf β1/product/R&D Systems
Average 96 stars, based on 1 article reviews
tgf β1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

91
Novus Biologicals d21490 tgf beta novus biologicals
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
D21490 Tgf Beta Novus Biologicals, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/d21490 tgf beta novus biologicals/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
d21490 tgf beta novus biologicals - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

95
Boster Bio tgfb1
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
Tgfb1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgfb1/product/Boster Bio
Average 95 stars, based on 1 article reviews
tgfb1 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

97
R&D Systems recombinant mouse tgf β1 protein
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
Recombinant Mouse Tgf β1 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse tgf β1 protein/product/R&D Systems
Average 97 stars, based on 1 article reviews
recombinant mouse tgf β1 protein - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

93
R&D Systems recombinant mouse tgf 1
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
Recombinant Mouse Tgf 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse tgf 1/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant mouse tgf 1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Bioss recombinant mouse tgf β1 protein
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
Recombinant Mouse Tgf β1 Protein, supplied by Bioss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse tgf β1 protein/product/Bioss
Average 96 stars, based on 1 article reviews
recombinant mouse tgf β1 protein - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Sino Biological mouse / rat tgf-beta 1 / tgfb1 protein
Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose <t>TGF-β</t> (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.
Mouse / Rat Tgf Beta 1 / Tgfb1 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse / rat tgf-beta 1 / tgfb1 protein/product/Sino Biological
Average 94 stars, based on 1 article reviews
mouse / rat tgf-beta 1 / tgfb1 protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose TGF-β (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.

Journal: Journal of Immunology (Baltimore, Md. : 1950)

Article Title: Notch Ligand Delta-Like 4 Blockade Alleviates Experimental Autoimmune Encephalomyelitis by Promoting Regulatory T Cell Development

doi: 10.4049/jimmunol.1100725

Figure Lengend Snippet: Dll4-mediated signaling regulates Treg expansion in vivo and in vitro. EAE was induced in C57BL/6 mice immunized with MOG(35–55)/CFA and treated with anti-DLL4 blocking Ab or control IgG every other day and for a total of five injections (arrows) starting on the day of the immunization. A, Flow cytometry plots from individual mice from each group for CD4 and Foxp3 staining of splenocytes or lymph node cells on DPI 10 (preclinical disease) and spinal cord cells on DPI 14 (peak of disease). Results are representative of three independent experiments with five mice per group. B, Statistical analysis of staining described in A. *p < 0.05, **p < 0.005 by unpaired t test. CD4+Foxp3− T cells (C) or total CD4+ T cells (D) were isolated from naive Foxp3.GFP.KI mice and stimulated in vitro with plate-bound anti-CD3 and anti-CD28 (1 µg/ml) in the presence of plate-bound rDll4 or control IgG (2 ug/ml). Optimal dose TGF-β (3 ng/ml) or IL-2 (20 ng/ml) was added to the culture medium when indicated and then supplemented to the culture medium on day 2 of culture. Cells were washed and stained for CD4 and Foxp3 on day 4 of culture. Results are representative of three independent experiments.

Article Snippet: Recombinant mouse Dll4-Fc fusion protein, IL-2, and TGF-β1 were purchased from R&D Systems.

Techniques: In Vivo, In Vitro, Blocking Assay, Flow Cytometry, Staining, Isolation